Opioid Rehab Near You: MAT, Detox & Recovery Programs
Browse SAMHSA-listed opioid rehab programs across all 50 states — filter by MAT type (buprenorphine, methadone, naltrexone), level of care (OTP, OBOT, residential, IOP, telehealth), and insurance acceptance. MAT reduces opioid overdose deaths by more than 50% (NIDA), yet fewer than 20% of people with OUD receive it. Synthetic opioids (primarily fentanyl) drive ~75% of US opioid overdose deaths — CDC reports over 80,000 annually. After the 2023 MAT Act, any licensed prescriber can offer buprenorphine in office-based or telehealth settings.
Found 9,319 rehab centers specializing in opioid addiction across the United States.
Need Help Finding the Right Treatment Center?
Speak with a compassionate specialist now - 100% free & confidential
Find Opioid Treatment Centers Near You
Browse opioid treatment centers below. Filter by MAT availability, state, insurance, and level of care to find the right program for your recovery needs.
Showing 20 of 9319 results
WhiteSands Alcohol and Drug Rehab in Lakeland, FL, delivers complete care for individuals struggling with addiction and co-occurring mental health challenges. They provide a range of treatment levels, including intensive outpatient, outpatient, and general outpatient services, employing proven methods such as 12-step support, anger management techniques, and brief therapeutic interventions. Recognizing varied needs, WhiteSands offers distinct programs for active military personnel, men, and women, ensuring gender-sensitive support. The center prioritizes exceptional, personalized treatment to foster enduring recovery for all clients.
WhiteSands Alcohol and Drug Rehab in Sarasota, FL, provides thorough addiction treatment for adults and young adults. They offer transitional living arrangements and address co-occurring mental health and substance use disorders. The facility features intensive outpatient and outpatient services, incorporating specific therapies like 12-step support and anger resolution. Distinctive programs are offered for active military personnel, as well as adult men and women. WhiteSands is committed to high-quality care, serving both male and female individuals in a nurturing and successful recovery setting.
WhiteSands Alcohol and Drug Rehab in Palm Harbor, FL, provides extensive care for individuals struggling with addiction, catering to both adults and adolescents. The center excels in addressing dual diagnoses, treating co-occurring substance use disorders alongside significant mental health conditions in adults, and severe emotional issues in children. Their therapeutic offerings include intensive outpatient, outpatient, and standard outpatient programs, all delivered through personalized approaches like 12-step facilitation, anger management techniques, and brief intervention strategies. WhiteSands also features distinct programs designed for active military personnel, adult men, and adult women. Prioritizing high-standard care and bespoke treatment journeys, WhiteSands is committed to guiding individuals toward enduring sobriety.
WhiteSands Alcohol and Drug Rehab in Melbourne, FL is a premier facility dedicated to providing thorough addiction and mental health care for adults and young adults. They offer a spectrum of services, including intensive outpatient, outpatient, and medication-assisted treatment using methadone, buprenorphine, or naltrexone. Their therapeutic approach emphasizes 12-step facilitation, anger management, and brief intervention strategies. The center proudly serves adult men and women, along with active duty military members, with distinct, personalized programs designed for each gender to ensure optimal recovery outcomes. WhiteSands Alcohol and Drug Rehab is committed to delivering exceptional, research-supported treatment for individuals battling substance use disorders and co-occurring mental health conditions.
Whitman Walker Clinic/Mental Hlth in Washington, DC provides expert outpatient services for individuals dealing with substance abuse and concurrent severe mental health conditions. The facility employs proven therapeutic methods such as cognitive behavioral therapy and motivational interviewing. Emphasizing care sensitive to past trauma, this center supports individuals living with HIV or AIDS, as well as those with dual diagnoses. Whitman Walker Clinic/Mental Hlth offers outpatient medication-assisted treatment (methadone, buprenorphine, naltrexone) and general outpatient care for adults and young adults across the gender spectrum. Their commitment is to offering thorough, top-tier support for those pursuing recovery.
Wholeview Wellness LLC, situated in New York, NY, delivers extensive treatment for adults dealing with substance use issues alongside severe mental health problems or emotional challenges in children. The center specializes in both intensive outpatient and regular outpatient services, offering treatments such as methadone/buprenorphine and naltrexone. It features targeted programs for active military personnel, as well as for adult men and women, addressing a wide range of requirements. With methodologies that include 12-step facilitation, anger management, and brief intervention, the center prioritizes customized support for adults and young adults of every gender. Wholeview Wellness LLC is recognized for its exceptional care and individualized programs that assist people in their recovery journey.
Situated in Wickenburg, AZ, Wickenburg Health Home provides expert outpatient treatment for substance use tailored for both adults and young adults. The center is particularly adept at assisting those who are grappling with simultaneous mental health issues and substance use disorders. Employing scientifically validated methods, including cognitive behavioral therapy and motivational interviewing, this facility offers extensive care for both male and female patients. Emphasizing short-term interventions and consistent outpatient support, Wickenburg Health Home commits to offering top-tier services designed to cater to the distinct requirements of each person on their path to recovery.
Situated in Salisbury, MD, the Wicomico County Health Department provides dedicated treatment programs for substance use specifically designed for both adults and young adults. This center offers a range of outpatient services, such as treatments with methadone or buprenorphine, naltrexone therapy, cognitive behavioral therapy, the Matrix Model, and motivational interviewing. Emphasizing personalized attention, the facility serves adult males and females by creating customized treatment plans that address the unique requirements of each individual. Committed to delivering high-quality care, the center supports all clients on their journey to recovery.
Situated in Wilkes Barre, PA, the Wilkes Barre VA Medical Center provides extensive addiction recovery services aimed at both adults and young adults. This facility focuses on detoxification, treatment for substance use, and addressing co-occurring mental health disorders, offering inpatient care within a hospital setting. Their approach incorporates 12-step facilitation, anger management techniques, and brief interventions. The center features specialized programs for adult men, women, and those who have faced intimate partner violence, ensuring personalized treatment plans for every patient. Committed to delivering exceptional and compassionate care, the Wilkes Barre VA Medical Center strives to support individuals on their journey to overcoming addiction.
WhiteSands Alcohol and Drug Rehab in Titusville, FL is dedicated to treating adults with addiction and co-occurring mental health conditions, along with children experiencing emotional issues. They offer various levels of care, including intensive outpatient and standard outpatient programs, and utilize medication-assisted treatment such as methadone, buprenorphine, or naltrexone. The center employs therapeutic strategies like 12-step facilitation, anger management, and brief intervention, specifically addressing the needs of active military members, adult men, and women. Serving a diverse population of adults and young adults, WhiteSands Alcohol and Drug Rehab emphasizes high-quality, personalized care to foster enduring recovery.
Hospital-based care in Whiteriver, Arizona, combining 24-hour inpatient detoxification with outpatient treatment that includes buprenorphine and naltrexone. Whiteriver Indian Hospital runs programs for pregnant and postpartum women, veterans, military families, people with HIV or AIDS, and clients with co-occurring disorders. Medicare, Medicaid, TRICARE, and IHS/Tribal/Urban funds are among accepted payments.
Whiteside Manor, located in Riverside, CA, provides targeted substance abuse rehabilitation for adult males. The center features a variety of treatment options, including intensive outpatient, long-term residential, and regular outpatient services, all designed to address the unique requirements of each client. Emphasizing 12-step principles, techniques for managing anger, and short-term intervention strategies, this facility focuses on individuals who have faced trauma as well as those dealing with both mental health and substance abuse issues. Catering to adults, seniors, and young adults, Whiteside Manor is committed to delivering excellent care through a professional staff. If you are looking for effective addiction recovery in a nurturing setting, this center provides extensive programs to help you on your journey to healing.
Whitman Walker Health in Washington, DC, provides outpatient substance use treatment with buprenorphine and naltrexone, with programs for clients with HIV or AIDS, co-occurring mental health disorders, and trauma histories. Medicare, Medicaid, TRICARE, and SAMHSA block grants are accepted, and sign language services are available.
The Max Robinson Center at Whitman Walker Health in Washington, DC, delivers outpatient substance use treatment with buprenorphine and naltrexone, focusing on clients with HIV or AIDS, trauma histories, and co-occurring mental disorders. Payment options include Medicaid, Medicare, TRICARE, and SAMHSA block grants. Sign language services are offered.
Methadone and buprenorphine treatment for opioid use disorder is the focus of this outpatient center in Wichita, Kansas. Programs serve adult women, pregnant and postpartum women, adult men, criminal justice clients, and people with co-occurring disorders or trauma. Federal funding, Medicare, Medicaid, TRICARE, SAMHSA block grants, and private insurance are accepted.
This VA outpatient clinic in Wilkes Barre, PA, provides substance use treatment for veterans at regular and intensive outpatient levels, including buprenorphine and naltrexone for opioid or alcohol use disorders. Co-occurring serious mental illness is also treated. Federal military insurance such as TRICARE is accepted, and sign language services are available.
Veterans near Wilkes Barre, PA, receive outpatient and intensive outpatient addiction treatment through this VA clinic, with buprenorphine and naltrexone available for medication-assisted treatment. Adults with co-occurring substance use and serious mental illness are served. TRICARE and federal military insurance cover care, and sign language services are offered.
Situated in Albany, NY, Whitney M Young Jr Health Center Inc specializes in a wide range of substance abuse treatment options. This facility offers intensive outpatient programs, standard outpatient services, and specific outpatient treatments utilizing methadone, buprenorphine, or naltrexone. With methodologies that include 12-step facilitation, brief interventions, and cognitive behavioral therapy, the center addresses the needs of adult men and women, including those who have faced trauma. Catering to both adults and young adults from diverse backgrounds, the center prioritizes personalized care and support. By focusing on high-quality treatment and tailored programs, Whitney M Young Jr Health Center Inc stands as a reliable choice for individuals in need of effective rehabilitation services.
Situated in Albany, NY, the Whitney M Young Jr Health Center Inc specializes in providing comprehensive treatment for substance use disorders. The center offers a range of services, including intensive outpatient programs, standard outpatient care, and treatment options involving methadone, buprenorphine, or naltrexone. Utilizing evidence-based methods like 12-step facilitation, cognitive behavioral therapy, and motivational interviewing, the center emphasizes effective, research-supported techniques. Tailored programs are designed to meet the needs of adult men and women, as well as individuals who have faced trauma. Catering to both adults and young adults of all genders, this facility is committed to delivering individualized support and care for those on their path to recovery.
Wicomico Behavioral Health, situated in Salisbury, MD, delivers thorough recovery programs for those struggling with addiction and co-occurring psychological issues. The center offers advanced outpatient treatment, standard outpatient services, and tailored programs for younger individuals, adult men, and adult women. Utilizing strategies like brief intervention, cognitive behavioral therapy, and the Matrix Model, this institution serves both adults and children/adolescents. Wicomico Behavioral Health provides outpatient medication-assisted treatment including methadone/buprenorphine or naltrexone, ensuring personalized care for every client, with a commitment to excellent recovery support for all individuals, regardless of gender, on their path to healing.
Opioid Use Disorder (OUD): Key Facts
Classification
Opioid Use Disorder (OUD)
Prevalence
2.1 million adults with OUD in the US (SAMHSA)
Overdose deaths
80,000+ opioid overdose deaths/year in US (CDC)
Primary substances
Fentanyl, heroin, oxycodone, hydrocodone
Gold standard treatment
Medication-Assisted Treatment (MAT)
MAT effectiveness
Reduces overdose deaths by 50%+ (NIDA)
FDA-approved medications
Buprenorphine (Suboxone), Methadone, Naltrexone (Vivitrol)
Emergency reversal
Naloxone (Narcan)
Opioid Overdose Emergency: Know the Signs
An opioid overdose can kill within minutes. If you see these signs, act immediately:
Overdose warning signs
- Blue or purple lips and fingernails (cyanosis)
- Pinpoint (extremely small) pupils
- Slow, shallow, or stopped breathing
- Unresponsive to shouting or sternal rub
- Gurgling or choking sounds
- Limp body, pale or clammy skin
What to do
- Call 911 immediately — most states have Good Samaritan laws protecting callers
- Administer naloxone (Narcan) if available — nasal spray or injection
- Perform rescue breathing — one breath every 5 seconds
- Place in recovery position (on their side) to prevent choking
- Give a second dose of naloxone after 2-3 minutes if no response
- Stay until help arrives — naloxone wears off in 30-90 minutes
National Overdose Prevention Hotline: 911 | SAMHSA Helpline: 1-800-662-4357 (24/7, free, confidential)
What Is Opioid Use Disorder?
DSM-5 diagnostic criteria
Opioid Use Disorder (OUD) is a chronic, relapsing brain condition defined by the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). It is diagnosed when a person meets at least two of eleven criteria within a 12-month period, including: taking opioids in larger amounts or for longer than intended, persistent desire or unsuccessful efforts to cut down, spending excessive time obtaining or using opioids, cravings, failure to fulfill major obligations, continued use despite social or interpersonal problems, giving up important activities, use in physically hazardous situations, continued use despite physical or psychological problems, tolerance, and withdrawal.
Severity classification
OUD severity is classified based on the number of criteria met: mild (2-3 criteria), moderate (4-5 criteria), and severe (6 or more criteria). Severe OUD carries the highest risk of overdose death and typically requires the most intensive treatment, including medication-assisted treatment. Even mild OUD warrants professional intervention, as the disorder tends to progress without treatment.
Opioids vs. opiates
The term "opiates" refers specifically to natural compounds derived from the opium poppy (morphine, codeine). "Opioids" is the broader term that includes opiates plus semi-synthetic drugs (oxycodone, hydrocodone, heroin) and fully synthetic drugs (fentanyl, methadone, tramadol). All opioids bind to mu-opioid receptors in the brain, producing pain relief, euphoria, and respiratory depression — the mechanism that causes fatal overdoses.
The Opioid Epidemic: Fentanyl Crisis
Three waves of the opioid epidemic
The US opioid crisis has unfolded in three distinct waves. The first wave (1990s) was driven by aggressive marketing of prescription opioids — OxyContin, Vicodin, Percocet — leading doctors to overprescribe and millions of patients to develop dependence. The second wave (around 2010) saw a surge in heroin use as people with prescription opioid addiction shifted to cheaper, more accessible heroin. The third wave (2013-present) is defined by illicitly manufactured fentanyl and its analogs, which now account for the majority of opioid overdose deaths in the United States.
Why fentanyl changed everything
Fentanyl is a fully synthetic opioid that is 50-100 times more potent than morphine and approximately 50 times more potent than heroin. A lethal dose of fentanyl is just 2 milligrams — roughly the size of a few grains of salt. Because fentanyl is cheap to manufacture and extremely potent by weight, drug traffickers mix it into heroin, cocaine, methamphetamine, and counterfeit prescription pills. Many people who die from fentanyl overdoses did not know they were consuming it. Counterfeit pills made to look like oxycodone (M30), Xanax, or Adderall frequently contain lethal doses of fentanyl.
Current impact
According to the CDC, over 80,000 Americans die from opioid overdoses each year, with synthetic opioids (primarily illicit fentanyl) responsible for roughly 75% of those deaths. Opioid overdose is now the leading cause of accidental death for Americans under 50. The crisis affects every demographic, geographic region, and socioeconomic group in the country.
Opioid Withdrawal Timeline
Opioid withdrawal is intensely uncomfortable but rarely life-threatening on its own. The timeline varies depending on whether the person was using short-acting opioids (heroin, oxycodone, hydrocodone) or long-acting opioids (methadone, extended-release morphine).
Short-acting opioids (heroin, oxycodone)
- 6-12 hours: Onset of symptoms — anxiety, muscle aches, sweating, yawning, runny nose
- 24-48 hours: Escalation — insomnia, diarrhea, nausea, vomiting, abdominal cramps, dilated pupils
- 48-72 hours: Peak severity — intense cravings, body aches, goosebumps, rapid heartbeat
- 5-7 days: Acute symptoms begin to subside
- 1-2 weeks: Most physical symptoms resolve
Long-acting opioids (methadone, ER morphine)
- 24-48 hours: Delayed onset of symptoms
- 3-5 days: Symptoms escalate and peak
- 5-10 days: Peak and plateau of acute withdrawal
- 10-20 days: Gradual improvement of physical symptoms
- 2-3 weeks: Most acute symptoms resolve
Post-Acute Withdrawal Syndrome (PAWS)
After acute withdrawal resolves, many people experience Post-Acute Withdrawal Syndrome (PAWS) — a set of prolonged symptoms including anxiety, depression, insomnia, fatigue, difficulty concentrating, and mood swings that can persist for weeks to months. PAWS is the leading cause of relapse in the first year of recovery and is a key reason why ongoing treatment and support are essential after detox.
Why medical detox matters
While opioid withdrawal itself is rarely fatal, the extreme discomfort drives many people to relapse during detox — and relapse after a period of abstinence is when overdose risk is highest, because tolerance has decreased. Medically supervised detoxification uses medications like buprenorphine, clonidine, and comfort medications to manage symptoms safely, dramatically reducing relapse during the withdrawal period.
Medication-Assisted Treatment (MAT)
Medication-Assisted Treatment is the gold standard for opioid use disorder, combining FDA-approved medications with counseling and behavioral therapies. Research from NIDA shows MAT reduces opioid overdose deaths by more than 50%, decreases illicit opioid use, reduces criminal activity, improves social functioning, and increases treatment retention. Despite this evidence, fewer than 20% of people with OUD receive MAT — a treatment gap that costs tens of thousands of lives each year.
Buprenorphine (Suboxone)
Type: Partial opioid agonist
Buprenorphine activates opioid receptors just enough to prevent withdrawal and cravings without producing the intense euphoria of full agonists. It has a "ceiling effect," meaning higher doses do not increase effects — significantly reducing overdose risk. Suboxone combines buprenorphine with naloxone to deter misuse.
Setting: Can be prescribed by any licensed prescriber in office-based settings (OBOT), pharmacies, or telehealth.
Methadone
Type: Full opioid agonist
Methadone is a long-acting opioid that stabilizes brain chemistry, eliminates withdrawal symptoms, and blocks the euphoric effects of other opioids at proper doses. It has the longest track record of any MAT medication, with over 50 years of evidence supporting its effectiveness.
Setting: Must be dispensed daily at a certified Opioid Treatment Program (OTP/methadone clinic). Take-home doses earned over time with compliance.
Naltrexone (Vivitrol)
Type: Opioid antagonist (blocker)
Naltrexone completely blocks opioid receptors, preventing any opioid from producing effects. The extended-release injection (Vivitrol) is administered monthly and eliminates the need for daily medication adherence. Unlike buprenorphine and methadone, naltrexone has no abuse potential and is not a controlled substance.
Requirement: Patient must be fully detoxed (7-14 days opioid-free) before starting naltrexone to avoid precipitated withdrawal.
MAT medication comparison
The three FDA-approved MAT medications differ in mechanism, dispensing model, and patient fit. The table below summarizes the key distinctions:
| Medication | Type | DEA Schedule | Setting | Dispensing | Best for |
|---|---|---|---|---|---|
| Buprenorphine (Suboxone, Sublocade, Subutex, Zubsolv, Brixadi) | Partial agonist with ceiling effect | III | OBOT, telehealth, retail pharmacy | Take-home from day 1 (or monthly injection) | Most patients; rural areas; daily clinic not feasible |
| Methadone | Full mu-opioid agonist | II | OTP only (42 CFR Part 8) | Daily at clinic → take-home after 90 days | Severe OUD; prior buprenorphine failure; long-standing dependence |
| Naltrexone (Vivitrol) | Opioid antagonist (blocker) | Not controlled | Any prescriber; injection at clinic | Monthly IM injection (380 mg) | Highly motivated; post-detox (7-14 days opioid-free); no abuse potential desired |
All three are effective; the best choice is the one the patient will actually take consistently. Adherence, not pharmacology, is the dominant predictor of outcomes. Buprenorphine and methadone are first-line for active opioid use; naltrexone requires complete detox before initiation.
Types of Opioid Treatment Programs
OTP / Methadone Clinics
Opioid Treatment Programs are federally certified clinics that dispense methadone and provide comprehensive services including counseling, drug testing, and case management. Patients visit daily initially, earning take-home privileges over time.
OBOT (Office-Based Treatment)
Office-Based Opioid Treatment allows any licensed prescriber to treat OUD with buprenorphine in a standard medical office or via telehealth. This model dramatically increases access, especially in rural areas with no OTPs. Patients fill prescriptions at regular pharmacies.
Residential (inpatient) programs provide 24/7 structured care for 30-90 days. Best for severe OUD, polysubstance use, co-occurring mental health disorders, or patients who need separation from their environment. Most residential programs offer MAT as part of treatment.
IOP programs provide 9-20 hours of structured treatment per week while allowing patients to live at home. Combines group therapy, individual counseling, and MAT. Effective for moderate OUD or as a step-down from residential treatment.
Standard outpatient involves 1-2 sessions per week — typically individual therapy and/or group sessions combined with MAT. Suitable for mild to moderate OUD or as a long-term maintenance level of care after completing more intensive treatment.
Medical detox provides 3-7 days of supervised withdrawal management using medications to ease symptoms. Detox alone is not treatment — it must be followed by ongoing MAT and/or behavioral therapy. Detox without continued care has very high relapse rates.
Naloxone: The Overdose Reversal Medication
What naloxone does
Naloxone (brand name Narcan) is an opioid antagonist that rapidly reverses opioid overdose by displacing opioids from receptors in the brain. It restores normal breathing within 2-5 minutes in most cases. Naloxone has no effect on people who do not have opioids in their system and has virtually no abuse potential. Since 2023, Narcan nasal spray is available over the counter at pharmacies nationwide without a prescription.
How to use naloxone nasal spray
Using Narcan nasal spray requires no medical training:
- Peel back the package and remove the device
- Tilt the person's head back and insert the nozzle into one nostril
- Press the plunger firmly to deliver the full dose
- If no response in 2-3 minutes, administer a second dose in the other nostril
- Continue rescue breathing and call 911 — naloxone wears off in 30-90 minutes, and the person may stop breathing again
Where to get naloxone for free
Many harm reduction organizations, health departments, and community pharmacies distribute naloxone for free or at low cost. SAMHSA's Opioid Overdose Prevention Toolkit and state naloxone access programs provide resources. Most states have standing orders allowing pharmacists to dispense naloxone without an individual prescription. If you or someone you know uses opioids, carrying naloxone can save a life.
Frequently Asked Questions About Opioid Treatment
What is medication-assisted treatment (MAT) for opioid addiction?
Medication-Assisted Treatment (MAT) combines FDA-approved medications — methadone, buprenorphine (Suboxone), or naltrexone (Vivitrol) — with counseling and behavioral therapies. These medications reduce cravings, prevent withdrawal symptoms, and normalize brain chemistry, allowing people to focus on recovery. MAT is the most effective treatment for opioid use disorder: it reduces overdose deaths by more than 50%, decreases illicit drug use, and improves treatment retention rates (NIDA).
How long does opioid withdrawal last?
The withdrawal timeline depends on the opioid used. Short-acting opioids like heroin and oxycodone cause symptoms within 6-12 hours that peak at 48-72 hours and subside over 5-7 days. Long-acting opioids like methadone produce delayed symptoms starting at 24-48 hours, peaking at 3-5 days, and lasting up to 2-3 weeks. Post-acute withdrawal symptoms (PAWS) — including anxiety, insomnia, and mood instability — may persist for weeks to months after acute withdrawal resolves.
Is buprenorphine (Suboxone) just replacing one addiction with another?
No — this is one of the most harmful misconceptions in addiction medicine. Buprenorphine is a partial opioid agonist prescribed at stable, controlled doses as part of comprehensive treatment. It does not produce euphoria when taken as directed, eliminates cravings, prevents withdrawal, and allows people to function normally — work, care for families, and rebuild their lives. Taking buprenorphine for OUD is no different than taking insulin for diabetes: it is evidence-based medication for a chronic medical condition.
What should I look for in an opioid treatment center?
Look for centers offering MAT options (buprenorphine, methadone, and/or naltrexone), accreditation from CARF or The Joint Commission, licensed medical staff experienced in addiction medicine, comprehensive assessment with individualized treatment plans, evidence-based therapies (CBT, contingency management), family support services, and strong aftercare planning. Verify they accept your insurance and offer the appropriate level of care for your situation.
Can I work while in opioid treatment?
Yes, especially with outpatient MAT programs. Outpatient treatment — including OBOT (office-based buprenorphine) and standard outpatient counseling — allows you to maintain work, family, and social responsibilities while receiving care. Intensive Outpatient Programs (IOP) typically meet 9-20 hours per week and can often be scheduled around work. Many employers are required to support recovery under the ADA and FMLA. Residential treatment requires time away but provides the most intensive support for severe cases.
What is fentanyl and why is it so dangerous?
Fentanyl is a fully synthetic opioid that is 50-100 times more potent than morphine. A lethal dose is just 2 milligrams. It is increasingly found in the illicit drug supply, mixed into heroin, cocaine, methamphetamine, and counterfeit prescription pills — often without the user's knowledge. Fentanyl is now responsible for roughly 75% of all opioid overdose deaths in the United States. Treatment for fentanyl addiction typically requires MAT (often at higher buprenorphine or methadone doses), naloxone training, and comprehensive behavioral support.
How long does MAT treatment last?
There is no fixed duration for MAT — treatment length should be individualized. Research consistently shows that longer treatment produces better outcomes. The American Society of Addiction Medicine (ASAM) recommends a minimum of one year of MAT, and many addiction specialists recommend indefinite maintenance for people with severe OUD, as the risk of fatal overdose is highest in the period after discontinuing MAT. The decision to taper off medication should be made collaboratively with a treatment provider when the patient is stable, has strong support systems, and is not facing major life stressors.
Is fentanyl in the drug supply near me?
Almost certainly yes. Fentanyl has been detected in the illicit drug supply in all 50 states. It is routinely found in heroin, counterfeit prescription pills (especially fake oxycodone M30s, Xanax, and Adderall), cocaine, and methamphetamine. DEA lab testing shows that 7 out of 10 counterfeit pills seized contain a potentially lethal dose of fentanyl. Fentanyl test strips — which can detect fentanyl before use — are available for free from many harm reduction organizations, health departments, and community pharmacies. The safest assumption is that any illicit substance may contain fentanyl.
Medical Review and Sources
Trusted Resources
Substance Abuse and Mental Health Services Administration
Federal agency providing information, resources, and treatment locator for substance abuse and mental health.
Helpline: 1-800-662-4357
National Institute on Drug Abuse
NIH institute advancing science on drug use and addiction causes, consequences, and treatment.
National Institute on Alcohol Abuse and Alcoholism
NIH institute supporting research on alcohol's impact on health and providing treatment resources.
Ready To Start Opioid Treatment?
Opioid addiction is a medical condition — not a moral failure. Medication-assisted treatment saves lives. Speak with a specialist who can help you find the right MAT program, detox center, or residential facility — 100% free and confidential, available 24/7.
Browse opioid addiction programs in states with the most treatment options.
Related conditions, treatment approaches, and levels of care.